WWW.DISSERTATION.XLIBX.INFO
FREE ELECTRONIC LIBRARY - Dissertations, online materials
 
<< HOME
CONTACTS



Pages:   || 2 |

«Package leaflet: Information for the user Sulfasalazine 250mg/5ml Oral Suspension Read all of this leaflet carefully before you start taking this ...»

-- [ Page 1 ] --

Package leaflet: Information for the user

Sulfasalazine 250mg/5ml Oral Suspension

Read all of this leaflet carefully before you start taking this medicine because it contains important

information for you.

● Keep this leaflet. You may need to read it again.

● If you have any further questions, ask your doctor or your pharmacist.

● This medicine has been prescribed only for you. Do not pass it on to others. It may harm them, even

if their signs of illness are the same as yours.

● If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet:

1. What Sulfasalazine Suspension is and what it is used for

2. What you need to know before you take Sulfasalazine Suspension

3. How to take Sulfasalazine Suspension

4. Possible side effects

5. How to store Sulfasalazine Suspension

6. Contents of the pack and other information

1. What Sulfasalazine Suspension is and what it is used for The active ingredient in Sulfasalazine Suspension is sulfasalazine which is an anti-inflammatory drug and belongs to a group of medicines called aminosalicylates.

Your doctor may give you Sulfasalazine to treat and manage inflammatory bowel disease.

Inflammatory bowel disease The main forms of inflammatory bowel disease are Ulcerative Colitis and Crohn’s disease.

Although the diseases have some features in common, there are some important differences ● Ulcerative Colitis is an inflammatory disease which affects only the large bowel (colon and back passage). The lining of the bowel becomes inflamed (red and swollen) and symptoms include abdominal pain and diarrhoea (which may contain blood and mucus).

Sulfasalazine is used to control the flare-ups of ulcerative colitis. It may also be used at lower doses to prevent more flare-ups of ulcerative colitis ● Crohn’s disease is an inflammatory disease which may affect any part of the digestive system from the mouth to the anus, but it most commonly affects the last part of the small bowel and the first part of the large bowel. Symptoms include abdominal pain and diarrhoea (which may be bloody).

Sulfasalazine is used to control flare-ups of Crohn’s Disease.

2. What you need to know before you take Sulfasalazine Suspension Your doctor will perform complete blood counts and liver function tests before starting Sulfasalazine and every second week during the first three months of therapy. During the second three months, the same tests should be done once monthly and thereafter once every three months and as clinically indicated.

Urine analysis and an assessment of kidney function should also be done periodically during treatment with Sulfasalazine. Thereafter, monitoring will be performed as your doctor requires.

Do not take Sulfasalazine if you:

● are allergic (hypersensitive) to any of the ingredients of Sulfasalazine Suspension ● are allergic (hypersensitive) to salicylates (e.g. aspirin) or sulfonamides (e.g. a certain type of antibiotic) ● have a disease known as porphyria (a rare blood pigment disorder). Your doctor will have already told you if you have this disease.

Sulfasalazine should not be used in children under 2 years of age.

Potentially life-threatening skin rashes (Stevens-Johnson syndrome, toxic epidermal necrolysis) have been reported with the use of sulfasalazine, appearing initially as reddish target-like spots or circular patches often with central blisters on the trunk. Additional signs to look for include ulcers in the mouth, throat, nose, genitals and conjunctivitis (red and swollen eyes). These potentially life-threatening skin rashes are often accompanied by flu-like symptoms. The rash may progress to widespread blistering or peeling of the skin.

The highest risk for occurrence of serious skin reactions is within the first weeks of treatment. If you have developed Stevens-Johnson syndrome or toxic epidermal necrolysis with the use of sulfasalazine, you must not be re-started on sulfasalazine at any time. If you develop a rash or these skin symptoms, stop taking sulfasalazine, seek urgent advice from a doctor and tell him that you are taking this medicine.

Warnings and precautions

If you answer YES to any of the questions below tell your doctor or pharmacist before taking this medicine:

● Have you ever had any problems with your liver or kidneys?

● Have you been told by your doctor that you have an inherited condition in which the body doesn’t have enough of an enzyme known as glucose-6-dehydrogenase which helps red blood cells function normally or any serious blood disorders?

● Have you ever had asthma?

● If you are a child and have arthritis?

Other medicines and Sulfasalazine Tell your doctor or pharmacist if you are taking the following medicines as they may interact with

Sulfasalazine:

● any medicine for high blood sugar/diabetes ● methenamine, an antibiotic for treating urinary tract infections ● digoxin, used to treat heart failure ● folate, folic acid or folinic acid, sometimes taken during the first few weeks of pregnancy to reduce the risk of neural tube defects, e.g. Spina Bifida ● azathioprine and mercaptopurine, drugs used to suppress your body’s immune response in organ transplantation and certain chronic inflammations (e.g. rheumatoid arthritis) ● methotrexate, used to treat rheumatoid arthritis.





Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.

Sulfasalazine Suspension with food and drink Sulfasalazine Suspension should be taken with or after food.

Pregnancy Tell your doctor if you are pregnant, planning to become pregnant or become pregnant whilst taking this medicine.

Ask your doctor or pharmacist for advice before taking any medicine.

Breast-feeding You should avoid breast-feeding while taking this medicine. There have been reports of diarrhoea or blood in the stools of babies of breast-feeding mothers taking sulfasalazine.

Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines Sulfasalazine is unlikely to affect your ability to drive or use machines.

Sulfasalazine Suspension contains ethanol:

This medicine contains small amounts of ethanol (alcohol), less than 100mg per 5ml.

3. How to take Sulfasalazine Suspension The suspension should be taken with food. The doses should be evenly divided during the day.

Unless your doctor has told you otherwise, the usual doses for the following conditions are:

Ulcerative Colitis and Crohn’s Disease Adults and the Elderly Severe flare-ups: 20-40 ml four times a day, with other medicines such as steroids. Do not leave more than 8 hours between the evening and the following morning dose.

Mild/Moderate flare-ups: 20-40 ml four times a day, but not always with other medicines Ulcerative Colitis Maintenance: Once the flare-up is controlled the dose is slowly reduced to 40 ml each day.

Your doctor will tell you how to reduce your dose. This lower dose may be continued for some time to help stop other flare-ups.

Children 2 years of age and over Your doctor will tell you what dose your child will need to use. This will be based on your child’s weight.

How long should you use Sulfasalazine?

This depends on how well the suspension suits you. The suspension starts to work in a few days. If it works well, you may be using it for some time. Do not stop using the suspension just because you feel better without first talking to your doctor.

Ensure that you drink adequate fluids whilst you are taking this medicine. This is to avoid problems with your kidneys.

If you take more Sulfasalazine than you should Contact your nearest hospital casualty department or tell your doctor immediately, if you have taken too much suspension or if a child has taken your medicine.

Please take this leaflet and the suspension with you to the hospital casualty department or to your doctor.

If you forget to take Sulfasalazine If you forget to take a dose, take the next dose as usual. Do not take a double dose to make up for a missed one.

Continued overleaf

4. Possible side effects Like all medicines, Sulfasalazine can cause side effects, although not everybody gets them.

Stop taking Sulfasalazine and tell your doctor immediately if you experience any of the following symptoms after taking this medicine.

● An allergic reaction such as sudden wheeziness, difficulty in breathing, swelling of eyelids, face or lips, rash or itching (especially affecting the whole body) ● Potentially life-threatening skin rashes (Stevens-Johnson syndrome, toxic epidermal necrolysis) have been reported (see section 2). Frequency: very rare (affects less than 1 person in 10,000) ● If you have a serious skin condition with a rash (sometimes confined to the cheeks and bridge of the nose), peeling skin or blistering. It may be triggered or aggravated by sunlight. Should this occur, stop taking this medicine, avoid strong sunlight and contact your doctor immediately ● If you are generally feeling unwell, have a fever, have pains in your joints, hives, swollen glands, rash and itching. These may be signs of a condition known as serum sickness.

Your doctor will stop your treatment in these cases.

Tell your doctor immediately if you experience any of the following symptoms after taking this medicine

as they will stop treatment in these cases:

If you notice any unexplained bleeding or bruising, paleness, tiredness, fever, rash, severe sore throat, bleeding under the skin, difficulty getting over an infection and generally feeling unwell.

These may be the first signs of an abnormality of the blood, including decreases in the number of red and white blood cells or platelets. Your doctor may take regular blood samples to test for these effects.

Very common side effects which may affect more than 1 person in 10:

● indigestion, heartburn ● feeling sick (nausea) ● stomach pain.

Common side effects which may affect more than 1 person in 100:

● dizziness ● joint pain ● headache ● mouth ulcers ● changes in taste ● difficulty sleeping ● ringing in ears ● fever ● cough ● diarrhoea ● itching of the skin ● being sick ● protein in urine ● inflamed mouth (stomatitis) ● abdominal pain ● blood shot eyes and eye infections.

● severe chills

Uncommon side effects which may affect more than 1 person in 1000:

● depression ● hives ● shortness of breath ● puffiness around the eyes and face ● hair loss ● loss of balance.

Unknown side effects which have been reported since marketing this product ● loss of appetite ● inflammation of the pancreas ● yellowing of the skin or whites of the eyes ● skin colour change (to a light blue) (jaundice) ● blood vessel inflammation ● tingling, numbness, pains in hands and feet ● blood in urine ● fits, jerky uncontrolled movements ● urine or motions may become a ● seeing and hearing things that are not there yellow/orange colour which is normal (hallucinations) and harmless ● inflammation of the lining of the brain ● lung complications with breathlessness ● inflammation of the sac surrounding the ● impaired folic acid absorption heart (pericarditis) ● eczema of the skin ● severe diarrhoea ● kidney inflammation and kidney pain ● changes in smell ● liver disease (hepatitis) ● change in mental state, loss of memory ● temporary infertility in men. Fertility returns ● inflammation of the salivary glands on either when treatment is stopped. Normal side of the face contraception should still be used ● inflammation of the heart muscle ● other blood disorders including anaemia (myocarditis) and enlarged glands (lymph nodes).

Your doctor will be taking blood tests to check your blood and your kidneys before you start treatment and regularly during treatment. They will also measure substances produced by your liver known as enzymes (liver function tests) at regular intervals.

They may also test your urine for protein and blood.

Very rarely Sulfasalazine has caused permanent staining of extended wear soft contact lenses (see section 6 for further information).

If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Sulfasalazine Suspension ● Keep out of the sight and reach of children.

● Do not use Sulfasalazine Suspension after the expiry date which is stated on the bottle. The expiry date refers to the last day of that month. Take back to the pharmacy 1 month after you first open it.

● Store your medicine below 25°C in a dry place.

● Do not throw away any medicine via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. These measures will help to protect the environment.

14

6. Contents of the pack and other information What Sulfasalazine Suspension contains The active substance is sulfasalazine. Each 5ml of suspension contains 250mg of the active ingredient sulfasalazine.

The other ingredients are xanthan gum (E415), dispersible cellulose, acesulfame K (E950), orange flavour (containing ethanol and butylated hydroxyanisole (E320)), lemon flavour, polysorbate 80, sodium benzoate (E211), citric acid monohydrate (E330), sodium citrate (E331) and water.

Sulfasalazine has caused permanent staining of extended wear soft contact lenses.

Although this happened very rarely. Daily-wear soft contact lenses and gas permeable lenses respond to standard cleaning if this happens.



Pages:   || 2 |


Similar works:

«The Johns Hopkins Pediatric Inflammatory Bowel Disease Center at Johns Hopkins Children’s Center offers a multidisciplinary approach to the diagnosis and management of Crohn’s disease and ulcerative colitis from infancy to young adulthood. Working with the referring health care provider, our goal is to enable a child with these digestive diseases, known collectively as inflammatory bowel disease (IBD), to lead a healthy and active life by providing the highest quality medical and surgical...»

«Curriculum Vitae May 25, 2011 Yong Woo Lee, Ph.D. Department of Biomedical Sciences and Pathobiology (DBSP), School of Biomedical Engineering and Sciences (SBES), Virginia Polytechnic Institute and State University (Virginia Tech), Room 337 ICTAS Building (MC-0298), Stanger Street, Blacksburg, VA 24061. Phone: 540-231-8484, Fax: 540-231-9738, E-mail : ywlee@vt.edu www.vascular.sbes.vt.edu, www.sbes.vt.edu/people/faculty/primary/ywlee.html http://www.vetmed.vt.edu/org/dbsp/faculty/ywlee.asp,...»

«Welcome! Getting your eyes checked can help you be the vision of health. You may think you need an eye exam only when it’s time to update your eyewear prescription. But the truth is, an eye exam can spot the early signs of serious health conditions like diabetes and high blood pressure, so you can be treated sooner, rather than later. When you get your eyes checked every year, you’re helping your eyes—and possibly your whole body—stay well. Priority Health Vision provides access to...»

«Guideline for Managing Occupational Health and Safety in an Influenza Pandemic The aim of the guideline is to provide guidance and information from an Occupational Health and Safety perspective to the University community in the event of a pandemic. This Guideline links to the UQ Crisis Management Plan which aims to protect and support students, staff and the general public in crisis situations http://www.uq.edu.au/ohs/oh-s-policies-procedures-guidelines. and to the Managing OHS in an Influenza...»

«An Fc Domain Protein–Small Molecule Conjugate as an Enhanced Immunomodulator by Meng-Jung Chiang A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland August 2014 Abstract Small molecules as well as protein drugs have demonstrated tremendous success in clinical applications. Despite this success, their off-target effects diminish their pharmacologic value. Decades ago, innovations in molecular...»

«CHAPTER 1 Rich-Poor Differences in Health Care Financing Alexander S. Preker, Guy Carrin, David Dror, Melitta Jakab, William C. Hsiao, and Dyna Arhin-Tenkorang Abstract: Most community finance schemes have evolved in the context of severe economic constraints, political instability, and lack of good governance. Usually government taxation capacity is weak, formal mechanisms of social protection for vulnerable populations absent, and government oversight of the informal health sector lacking....»

«GRADUATE PROGRAM STUDENT HANDBOOK 2015-16 WELCOME TO THE DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOLOGY Biochemistry and Molecular Biology are sciences at the epicenter of modern biomedical research. Understanding basic biochemical pathways is key to gaining new knowledge for the prevention and combating of disease, allowing for the expansion of current boundaries in medicine and science. In addition to medical applications, molecular biology is indispensable for the development of tools...»

«Patient Information What you need to know about Non-Hodgkin Lymphoma This brochure is a part of a Patient Information Series supported by Baxter. This information is not meant to be a substitute for the advice provided by your own physician or other medical professional. You should not use this information for diagnosing a health problem or disease but should always consult your own physician.Acknowledgements: We would like to thank the U.S. Department of Health and Human Services, Public...»

«Literature Cited Literature cited Adriano DC (2001). Trace Elements in the Terrestrial Environment: Biogeochemistry. Bioavailability and Risks of Metals. 2nd edn. Springer, New York. Adriano DC, Bolan NS, Vangronsveld J, Wenzel WW (2004). Heavy metals. In: Encyclopedia of Soils in the Environment. Hillel D (Ed.), Elsevier, Amsterdam, pp.175-182. Adriano DC, Bollag JM, Frankenberger WT, Sims RC (1999). Bioremediation of Contaminated Soils. Agronomy monograph 37, American Society of Agronomy....»

«Guidelines for Antiretroviral Therapy for the Prevention and Treatment of HIV in Zimbabwe National Medicine and Therapeutics Policy Advisory Committee (NMTPAC) and The AIDS and TB Directorate, Ministry of Health and Child Care December 2013 Guidelines for Antiretroviral Therapy for the Prevention and Treatment of HIV in Zimbabwe, 2013 Published by: • The National Medicine and Therapeutics Policy Advisory Committee (NMTPAC) and • The AIDS and TB Directorate, Ministry of Health and Child...»

«Saving Faces: Art and Medicine Ted Kooser Thursday, January 26, 2006 7:00pm Thank you all for coming. It’s a wonderful honor for me to be here. Dr. Lydiatt and the University of Nebraska Medical Center saved my life and I owe them a great deal. I managed to survive head and neck cancer and then all these wonderful things happened to me. I wanted to begin tonight with a little poem that I wrote recently. Lots of my friends come up and put their hand on my shoulder and say, “How are you...»

«ABSTRACT Title of dissertation: THE ASSOCIATION BETWEEN ELECTRONIC CIGARETTE USE AND CIGARETTE SMOKING BEHAVIOR AMONG YOUNG ADULTS IN THE UNITED STATES Blair N. Coleman, Doctor of Philosophy, 2015 Dissertation directed by: Associate Professor Kerry M. Green Department of Behavioral and Community Health The prevalence of electronic cigarette (e-cigarette) use is rapidly increasing in adults and youth; however, little is known about the public health impact of their use. A debate over...»





 
<<  HOME   |    CONTACTS
2016 www.dissertation.xlibx.info - Dissertations, online materials

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.